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Summary
Expression of B cell-activating factor (BAFF), a critical
B cell survival factor, is elevated in autoimmune and
lymphoproliferative disorders. Mice overproducing
BAFF develop systemic lupus erythematosus (SLE)-
like disease and exhibit B cell activation of classical
and alternative NF-kB-signaling pathways. We used
a genetic approach and found that both NF-kB-signal-
ing pathways contributed to disease development but
act through distinct mechanisms. Whereas BAFF en-
hanced long-term B cell survival primarily through
the alternative, but not the classical, NF-kB pathway,
it promoted immunoglobulin class switching and gen-
eration of pathogenic antibodies through the classical
pathway. Activation of the alternative NF-kB pathway
resulted in integrin upregulation, thereby retaining au-
toreactive B cells in the splenic marginal zone, a com-
partment that contributes to their survival. Thus, both
classical and alternative NF-kB signaling are impor-
tant for development of lupus-like disease associated
with BAFF overproduction. The same mechanisms
may be involved in the pathogenesis of human SLE.
Introduction
Autoimmunity results from failed establishment and
maintenance of tolerance to self-antigens (Lesage and
Goodnow, 2001). Although many cell types contribute
to autoimmune disorders, lymphocytes are key effec-
tors in their initiation and propagation. During normal
lymphopoiesis, a few self-reactive B lymphocytes
emerge (Wardemann et al., 2003) but are normally si-
lenced by at least three different mechanisms: clonal de-
letion, development of anergy, and B cell receptor (BCR)
editing (Nemazee and Burki, 1989).
*Correspondence: karinoffice@ucsd.eduB cell-activating factor (BAFF, also known as BLyS or
TALL-1) is a fundamental B cell survival factor (Batten
et al., 2000) produced by myeloid cells, T cells, and dif-
ferent stromal cells (Mackay and Tangye, 2004). Three
BAFF receptors were identified: BCMA (B cell matura-
tion antigen), TACI (transmembrane activator and
CAML interactor), and BAFF-R (BAFF receptor or BR3)
(Mackay et al., 2003). BCMA and TACI also bind APRIL
(a proliferation-inducing ligand), whereas BAFF-R binds
only BAFF (Mackay et al., 2003). Studies with mice
harboring inactivating mutation of BAFF-R (Tnfrsf13c)
demonstrated that BAFF-R is required for mature B
cell survival in the periphery (Miller and Hayes, 1991).
In contrast, BCMA-deficient (Tnfrsf172/2) mice have
normal B cell numbers, whereas TACI-deficient
(Tnfrsf13b2/2) mice show a 2-fold increase in B cells
(von Bulow et al., 2001). Mice overexpressing BAFF
(BAFF-Tg mice) develop an autoimmune disease with
hallmarks resembling human systemic lupus erythema-
tosus (SLE), including autoantibodies against double-
stranded (ds)-DNA, circulating immune complexes,
and a severe membranoproliferative glomerulonephritis
(Mackay et al., 1999).
The inhibitor of kB (IkB) kinase (IKK) complex (Roth-
warf and Karin, 1999) activates via its two catalytic
subunits, IKKb and IKKa, the classical and alternative
NF-kB-signaling pathways, respectively, that play im-
portant roles in innate and adaptive immunity (Bonizzi
and Karin, 2004). The classical NF-kB pathway targets
dimers composed of p65 (RelA), c-Rel, and NF-kB1
(p50), which are retained in the cytoplasm by IkB pro-
teins (Ghosh et al., 1998). Activation of this pathway
causes phosphorylation of IkBs and their subsequent
degradation, allowing nuclear entry of liberated NF-kB
dimers (Karin and Ben-Neriah, 2000). The alternative
NF-kB pathway depends on IKKa dimers that phosphor-
ylate the NF-kB2 (p100) precursor protein, leading to
degradation of its C-terminal half and release of its N-
terminal portion, p52, that enters the nucleus as a dimer
with RelB (Senftleben et al., 2001a). Whereas all three
BAFF receptors activate the classical NF-kB pathway,
only BAFF-R activates the alternative NF-kB pathway
(Claudio et al., 2002).
We examined which NF-kB pathway and which B cell
type are involved in development of SLE-like autoim-
mune disease in BAFF-Tg mice. Given the known path-
ogenic role of high-affinity dsDNA autoantibodies in
SLE, it was anticipated that the CD40-dependent germi-
nal center (GC) reaction, in which B cells undergo affinity
maturation and Ig class switching, would be essential
for disease development (McHeyzer-Williams, 2003).
However, we found that CD40-dependent GC formation
was not required for development of SLE-like disease. In
contrast, another splenic B cell compartment, the mar-
ginal zone (MZ), turned out to be critical. The enlarged
MZ B cell pool of BAFF-Tg mice, in which B cell survival
depends mainly on the alternative NF-kB pathway, har-
bors the majority of autoreactive B cells, and its elimina-
tion or reduction prevents or strongly diminishes the
disease.
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404Figure 1. BAFF-Tg Mice Develop a SLE-like Autoimmune Disease Dependent on Both NF-kB Pathways
(A) dsDNA autoantibody titers monitored over a 10 month period in BAFF-Tg, BAFF-Tg compound mutants, and splenectomized (2sp) BAFF-Tg
mice. Values represent relative mean 6 SD. OD405 measurements of autoantibody titers at different ages in 8 mice per genotype or treatment.
Statistically significant differences (p < 0.01) between mutants and wt controls are indicated by asterisks.
(B) Lesion scores mean6 SD of kidneys from 10-month-old mice (n = 8) of the indicated cohorts. Asterisks indicate significant changes (p < 0.01)
from the wt.
(C) Top: Periodic acid Schiff-(PAS)-stained kidneys of BAFF-Tg and BAFF-TgIkkaAA/AA mice, 203magnification. Thin arrows point to basement
membranes, thick arrow marks necrotic zone. Bottom: Immunohistology via a PE-labeled anti-IgG antibody to identify glomerular IgG deposits.Results
Disruption of Either NF-kB Pathway or Splenectomy
Prevents or Strongly Reduces Autoimmune Disease
in BAFF-Tg Mice
The roles of the classical and alternative NF-kB path-
ways, as well as CD40, in development of SLE-like dis-
ease in mice that overexpress BAFF were examined. Be-
cause BAFF-Tg mice exhibit marked splenomegaly
(Mackay et al., 1999), some mice were splenectomized
at 3 weeks of age to evaluate the role of the spleen in dis-
ease development. In addition, we used cohorts of eight
age-matched mice that were either wild-type (wt) or de-
ficient in various components of the classical and alter-
native NF-kB pathways. All mice were monitored for
dsDNA autoantibody titers of IgM, IgG subclasses, and
IgA and for proteinuria (Balow, 2005).
Production of IgM dsDNA autoantibodies in BAFF-Tg
mice required the alternative NF-kB pathway, because
these titers were markedly reduced in BAFF-TgIkkaAA/AA
mice, which express a variant of IKKa that can not be ac-
tivated, or were absent upon loss of NF-kB2 (Figure 1A).
IgM autoantibody production, however, was not im-
paired by the absence of NF-kB1 or CD40. Interruptionof either NF-kB1 or NF-kB2 signaling, but not loss of
CD40, prevented generation of dsDNA autoantibodies
of the IgG subclasses and IgA. Although early splenec-
tomy had only a partial effect on concentrations of IgM
and IgA autoantibodies, it markedly reduced IgG auto-
antibody production. dsDNA autoantibody titers did
not differ by gender and were undetectable in mice with-
out the transgene encoding BAFF. No nonspecific auto-
antibody binding to bovine serum albumin could be
found, ruling out contribution of polyreactive back-
ground Igs (data not shown). Only mice with high IgG au-
toantibody titers developed a considerable proteinuria
(Table 1).
At 10 months of age, mice were sacrificed and kidneys
were analyzed. Only mice with high titers of IgG dsDNA
autoantibodies exhibited severe kidney lesions,
whereas kidney lesions were mild or absent in mice
without IgG autoantibodies, regardless of IgM or IgA au-
toantibody concentrations (Figures 1B and 1C). Immu-
nohistology of kidneys with severe lesions revealed
numerous glomerular deposits of IgG (Figure 1C).
Thus, the spleen and intact classical and alternative
NF-kB pathways, but not CD40, are required for disease
development.
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405Table 1. Proteinuria in 8-Month-Old Mice of Different Genotypes
Mouse 1 2 3 4 5 6 7 8
wt — — — (+) — — + (+)
BAFF-Tg ++ ++ +++ +++ ++ + +++ ++
BAFF-TgCd402/2 +++ +++ +++ ++ ++ +++ ++ ++
BAFF-TgIkkaAA + + (+) — + + + +
BAFF-TgNfkb22/2 — — (+) — — — + —
BAFF-TgNfkb12/2 — — (+) + + + — —
BAFF-Tg - spleen + + +(+) — + + + (+)
Quantification of proteinuria: + 30 mg/dl; ++ 100 mg/dl; +++ 300 mg/dl.BAFF Controls B Cell Survival via Classical
and Alternative NF-kB Pathways
Disruption of the alternative NF-kB pathway, as in
splenic B cells isolated from IkkaAA/AA, Ikka2/2 trans-
planted wt, or Nfkb22/2 mice, and loss of BAFF-R re-
duced or abrogated the prosurvival effect of BAFF
(Figure 2A). Also, BAFF stimulation of Nfkb12/2 B cells
did not significantly enhance in vitro survival within the
first 12 hr. When present for 24 hr or longer, however,
BAFF enhanced the survival of Nfkb12/2 B cells almost
as effectively as in wt B cells.
Whereas IKKa- or BAFF-R-deficient B cells were un-
able to process p100 upon BAFF stimulation, residual
p100 processing to p52 was seen in IkkaAA/AA B cells
(Figure 2B). The degree of p100 processing correlated
with the survival advantage conferred by BAFF, not
only in vitro, but also in vivo. In this regard, splenic B
cell numbers were 70%–80% lower than normal in B
cell-deficient BAFF-TgmMT mice, which were trans-
planted with fetal liver cells from IKKa-deficient em-
bryos, or in BAFF-TgNfkb22/2 mice (wt / BAFF-
TgmMT, splenic B cells: 656 7.43 106; Ikka2/2 fetal liver
cells / BAFF-TgmMT: 13.5 6 1.9 3 106; BAFF-
TgNfkb22/2: 16.1 6 2.7 3 106; n = 5). Congruent with
their ability to produce some p52 in response to BAFF,
BAFF-TgIkkaAA/AA mice contained as many splenic B
cells as wt mice, but much fewer B cells than BAFF-Tg
mice (BAFF-TgIkkaAA/AA, splenic B cells: 34 6 4.5 3
106; wt: 326 2.83 106, BAFF-Tg: 766 8.33 106; n = 5).
As expected by the partial requirement of NF-kB1 for
BAFF-mediated short-term survival, BAFF activated the
classical NF-kB pathway. Electroporetic mobility shift
assays (EMSAs), as well as immunoblotting with an
IkBa antibody, revealed activated classical NF-kB sig-
naling within 3 hr after BAFF addition (Figure 2E, see
Figure S1 in the Supplemental Data available online).
Stimulation with BAFF not only induced p50:p65 dimers
but also enhanced formation of p50 homodimers. Addi-
tion of BAFF-neutralizing BR3-Fc immunoadhesin com-
pletely prevented activation of the classical pathway, in-
dicating that the response was due to BAFF rather than
unknown contaminants. In agreement with previous ob-
servations (Bonizzi et al., 2004), BAFF activation of the
classical NF-kB pathway was normal in IkkaAA/AA and
Nfkb22/2 B cells. Earlier studies suggested that BAFF
activates the classical NF-kB pathway through TACI
and BCMA (Marsters et al., 2000). However, we found
modest, but reproducible, reduction in NF-kB binding
activity in B cells from BAFF-R-deficient mice. Thus,
BAFF-R also contributes to activation of the classical
pathway. This observation was substantiated byimpaired IkBa degradation in BAFF-stimulated B cells
from BAFF-R-deficient mice (Figure S1). BAFF-R-defi-
cient B cells expressed BCMA and TACI at amounts
similar to wt B cells (data not shown). Nonetheless,
a much greater impairment of classical NF-kB signaling
was found in B cells from NF-kB1- or TACI-deficient
mice. DNA binding complexes in Nfkb12/2 B cells in-
duced by BAFF primarily consisted of p52:RelB and
p65:RelB dimers (Figure 2E).
Besides upregulation of the antiapoptotic proteins
Bcl-XL and A1/Bfl1, whose maximal induction required
both NF-kB pathways (Hatada et al., 2003), BAFF-in-
duced long-term survival correlated with upregulation
of Pim-2, which depended only on the alternative path-
way (Figures 2C and 2D). Pim-2 is a serine and threonine
kinase that phosphorylates the proapoptotic protein
Bad at Ser112, resulting in its inactivation (Fox et al.,
2005). Correspondingly, BAFF-induced Bad Ser112
phosphorylation was dependent on the alternative path-
way and correlated with Pim-2 amounts (Figure 2D).
Moreover, the survival curves of BAFF-stimulated
Pim22/2orNfkb22/2B cells were very similar (Figure 2A).
Defects in either NF-kB pathway had no effect on Pim-1
or Pim-3 expression (data not shown). Taken together,
BAFF enhances short- and long-term survival of B cells
primarily via the classical and alternative NF-kB signal-
ing pathways, respectively.
BAFF Induces In Vivo Expansion of Transitional T1
and T2 B Cells
BM-derived B cell precursors pass through intermediate
differentiation stages in the spleen, which can be distin-
guished as transitional (T) 1 (B220+AA-4.1+CD21loCD23hi
CD24hi) and T2 (B220+AA-4.1+CD21hiCD23hiCD24hi)
(Goodyear et al., 2004; Loder et al., 1999). Precursors
from either healthy individuals or SLE patients produce
comparable amounts of antinuclear autoantibodies
(ANAs), whereas mature naive B cells from SLE patients
generate many more ANAs than B cells from normal indi-
viduals. It was therefore suggested that ANA-producing
B cells in SLE patients are not eliminated at the splenic
transitional stage (Yurasov et al., 2005).
Accordingly, we examined effects of BAFF and NF-kB
signaling on survival of transitional B cells. In contrast to
previous reports, we found that BAFF enhanced the rep-
resentation not only of T2 cells (Batten et al., 2000) but
also of T1 cells (Figure 3), without affecting cell-cycle
distribution (S + G2 phase of B220+AA-4.1+CD24hi B
cells from wt and BAFF-Tg mice were 8.2%6 0.3% ver-
sus 8.4% 6 0.3% of total; n = 3). This effect of BAFF
on transitional B cells was dependent on the NF-kB2
Immunity
406Figure 2. BAFF-Induced Long-Term Survival of CD32CD52CD432 Splenic B Cells Is Primarily Dependent on the Alternative NF-kB Pathway and
BAFF-R
(A) Effect of BAFF on in vitro survival, determined by trypan blue exclusion, of purified B cells from the indicated strains. Black curves represent
mean values 6 SD for cells from three individual mice. Gray curves: wt B cells. Lower left: Bars represent survival of B cells from the indicated
strains (n = 5) in the presence or absence of BAFF. Statistically significant effects (p < 0.05) on survival are indicated by asterisks.
(B) BAFF-induced NF-kB2 (p100) processing. B cells from different mouse strains (n = 3 mice per strain) were cultured for 12 hr with or without
BAFF before cell extracts were prepared, and processing of NF-kB2 (p100) was analyzed by immunoblotting.
(C) Expression of mRNAs for antiapoptotic proteins. B cells from different mouse strains were incubated with BAFF, and total RNA was isolated
at 0, 15, and 30 hr and analyzed for expression of different mRNAs as indicated by real-time PCR (mean 6 SD; n = 3).
(D) Expression of antiapoptotic proteins. Cellular extracts obtained as in (C) after 15 hr in presence (+) or absence (2) of BAFF were subjected to
immunoblot analysis with antibodies against the indicated proteins.
(E) Analysis of NF-kB binding activity. B cells (n = 3 mice per strain) were cultured for 3 hr, or as indicated, with or without BAFF. Nuclear extracts
were prepared and EMSAs were performed in the presence of antibodies against the indicated NF-kB subunits or with isotype IgG control. NF-kB
complexes as identified by supershift analysis are marked. Values underneath the panel represent mean relative signal intensities of total NF-kB
DNA binding activity. BR3-Fc was used to inhibit BAFF. Extract quality was monitored by binding to a NF-Y probe.component of the alternative pathway. The low amount
of p52 generation in BAFF-TgIkkaAA/AA mice seemed
sufficient to produce a slightly enlarged T2 but not
T1 B cell population. Analysis of transitional B cells
from BAFF-TgNfkb12/2 mice showed a similar increase
in T1 and T2 B cells as in BAFF-Tg mice. Thus,
BAFF expands T1 and T2 transitional B cells mainly
through activation of the alternative NF-kB signaling
pathway.BAFF Strongly Enhances Thymus-Independent Ig
Class Switching, even without T Cells
Immunization of BAFF-Tg and BAFF-TgCd402/2 mice
with the thymus-independent (TI) antigens DNP-Ficoll
or DNP-LPS generated equally potent anti-DNP re-
sponses of the IgG1, IgG2a, IgG2b, IgG3, and IgA clas-
ses, which were significantly stronger than those in wt
mice (Figures 4A and 4B). Anti-DNP responses of the
IgG1, IgG3, and IgA classes were markedly reduced in
NF-kB Signaling in Autoimmunity
407Figure 3. Analysis of Transitional T1 and T2 B Cells in Different Mouse Strains
Equal numbers of B220+AA-4.1+-sorted splenocytes from three mice per strain were analyzed by flow cytometry with different markers. T1 cells
are CD21loCD24hi. T2 cells are CD21hiCD23hi. The numbers represent percentages mean 6 SD of gated cells compared to total B220+AA-4.1+
cells. One representative experiment is shown.BAFF-Tg mice with defective alternative NF-kB signal-
ing, such as BAFF-TgNfkb22/2 or BAFF-TgIkkaAA/AA
mice, while the IgM, IgG2a, and IgG2b responses were
less affected. Conversely, interference with the classical
NF-kB pathway in BAFF-TgNfkb12/2 mice significantly
reduced the IgG2a and IgG2b responses and virtually
abrogated the IgG3 and IgA responses, although titers
of IgM antibodies in BAFF-TgNfkb12/2 were higher
than in BAFF-Tg mice. Our observation that BAFF failed
to promote in vitro class switching in NF-kB1-deficient B
cells strongly suggested that activation of NF-kB1 by
BAFF is, indeed, essential for class switching (Figure S2).Similar to BAFF-TgNfkb12/2 mice, TI class switching
was substantially, but not as strongly, reduced in
BAFF-TgTACI-deficient mice (Figure S3A). TI class
switching was also impaired in BAFF-R-deficient mice
in the presence of excessive BAFF, indicating that
BAFF-induced Ig class switching is likely mediated
through both TACI and BAFF-R.
To test whether BAFF can promote TI class switching
in the absence of T cells, B220+-sorted B cells from wt
mice were transferred into Rag22/2 and BAFF-
TgRag22/2 mice. After 3 weeks, mice were immunized
with DNP-Ficoll, and serum was analyzed (Figure S3B).Figure 4. Antibody Responses after Immunizations with T1 and TD Antigens
(A) Antibody responses after DNP-LPS immunizations.
(B) Antibody responses after DNP-Ficoll immunizations.
(C) Antibody responses after DNP-KLH immunizations. These mice were rechallenged at day 21.
From all the mice, serum was taken at days 0, 7, 14, 21, and in the case of DNP-KLH, also at day 28 postimmunization. Values represent mean6
SD. OD405 results of antigen-specific ELISAs (n = 5 mice per strain). Asterisks indicate significant differences (p < 0.01) from wt controls.
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absence of T cells and could be only weakly enhanced
by BAFF. Reduced class switching to IgG2a and IgG3,
relative to BAFF-Tg mice, was also observed. Class
switching to these isotypes, however, was still higher
in BAFF-TgRag22/2 mice than in Rag22/2 mice, indicat-
ing that BAFF promotes switching to IgG2a and IgG3
even in absence of T cells. Interestingly, induction of
IgG2b and IgA by BAFF was unaffected by the absence
of T cells. Similar immune responses were induced un-
der excessive BAFF in Tcrbd2/2mice, which lack mature
T cells. Because we did not have these mice available as
BAFF-Tg compound mutants, we injected them with 5
mg of recombinant BAFF every other day starting on
day of immunization. As seen in B cell-transplanted
BAFF-TgRag22/2 mice, BAFF administration had virtu-
ally no effect on the IgG1 response, but substantially en-
hanced the IgM, IgG2a, IgG2b, IgG3, and IgA responses.
Collectively, these results indicate that BAFF can pro-
mote class switching to the IgG2a, IgG2b, IgG3, and
IgA isotypes without T cells.
The effect of BAFF on Ig class switching in response
to TI antigens was not as pronounced when mice
were immunized with the thymus-dependent (TD) anti-
gen DNP-KLH (Figure 4C). Not surprisingly, BAFF-
TgCd402/2 mice exhibited reduced class switching
relative to BAFF-Tg mice in response to TD antigen,
reflecting the missing CD40-based B cell-T cell interac-
tions. Correspondingly, CD40-deficient mice remained
defective in GC formation (Oxenius et al., 1996), even
upon BAFF overexpression (Figure S4).
BAFF Promotes B Cell Retention in Splenic MZ
BAFF overexpression markedly increased the number of
splenic CD21hiCD232 B cells, which represent the dom-
inant B cell population of the MZ compartment (Thien
et al., 2004), and expanded the size of the MZ (Figures
5A and 5B). Complete disruption of the alternative NF-
kB pathway in BAFF-TgNfkb22/2mice caused nearly to-
tal loss of CD21hiCD232 B cells and splenic microarchi-
tecture. A similar defect was found upon interference
with the classical pathway in BAFF-TgNfkb12/2 mice.
Whereas these mice maintained splenic compartmen-
talization, they had no MZ B cells. In contrast, loss of
CD40 had no effect on the MZ B cell compartment. In-
complete disruption of the alternative NF-kB pathway
in BAFF-TgIkkaAA/AA mice led only to a partial reduction
in the number of CD21hiCD232 B cells. The spleens of
BAFF-TgIkkaAA/AA mice, however, did not show normal
compartmentalization and the MZ could not be localized
properly (Figure 5B). Nevertheless, the presence of
other markers typical of MZ B cells, such as CD1d and
CD9 (Roark et al., 1998; Won and Kearney, 2002), con-
firmed the MZ phenotype of the CD21hiCD232 B cells
in these mice (Figure S5). Transplantation of wt BM
into lethally irradiated BAFF-TgIkkaAA/AA mice com-
pletely restored splenic microarchitecture, indicating
that the defect in the BAFF-TgIkkaAA/AA mice is intrinsic
to hematopoietic cells. As expected, these radiation chi-
meras developed dsDNA autoantibodies and glomeru-
lonephritis with similar kinetics and severity as BAFF-
Tg mice (data not shown). This observation excludes
a pathogenic role for the alternative NF-kB pathway
within splenic stromal or kidney parenchymal cells.Long-term retention of B cells within the MZ was re-
ported to depend on expression of aLb2 (LFA-1) and
a4b1 but not a4b7 integrins (Lu and Cyster, 2002). Integ-
rins aLb2 and a4b1 are present on MZ B cells and recog-
nize VCAM-1 and ICAM-1, which are expressed by MZ
stromal cells and MZ macrophages in response to lym-
photoxin-b receptor (LTb-R) signaling via the classical
NF-kB pathway (Dejardin et al., 2002; Lu and Cyster,
2002). Low VCAM-1 and ICAM-1 expression in mice
with defective classical NF-kB pathway (not shown)
may explain, at least in part, the MZ B cell deficiency
in BAFF-TgNfkb12/2 mice (Figures 5A and 5B).
Because BAFF expanded the MZ B cell compartment,
we wondered whether BAFF could induce aL, a4, b1,
and b2 integrin subunit mRNAs in cultured wt B cells
(Figure S6). This was indeed the case, whereas integrin
b7 mRNA expression was not affected. We also exam-
ined integrin expression in splenic B cell populations
of BAFF-Tg mice with intact or interrupted alternative
NF-kB pathway. As found in vitro, BAFF enhanced ex-
pression of aL, a4, b1, and b2 mRNAs in CD21hiCD232
MZ and, to a lesser extent, in CD21+CD23hi FO B cells,
in a manner dependent on the alternative NF-kB path-
way (Figure 5C). Expression of b7 integrin mRNA was
downregulated in MZ B cells, but not FO B cells. Partial
disruption of the alternative NF-kB pathway, however,
led to upregulation of b7 in MZ B cells. Next, we exam-
ined the expression of integrins on the surface of
CD21hiCD232 MZ and CD21+CD23hi FO B cells
(Figure 5D). In concordance with the RNA analysis, aL,
a4, and b2 were markedly elevated in MZ B cells com-
pared to FO B cells. BAFF stimulated expression of
these integrin subunits in a manner dependent on the
alternative NF-kB pathway. Furthermore, a4b7 was
downregulated on MZ B cells of BAFF-Tg mice but upre-
gulated when the alternative NF-kB pathway was dis-
rupted. a4 also partners with b1, so downregulation of
a4b7 makes more a4 available for dimerization with b1,
resulting in more a4b1, which is important for B cell re-
tention in the MZ.
We then examined the functional relevance of BAFF-
induced aLb2 and a4b1 integrin upregulation. As seen
in wt mice (Lu and Cyster, 2002), treatment of BAFF-Tg
mice with a combination of a4 and aL blocking anti-
bodies rapidly reduced the number of splenic MZ B cells
(Figure 5E) and the size of the MZ B cell compartment
(data not shown). This treatment also led to appearance
of MZ B cells in the blood. Thus, BAFF overexpression
may enhance B cell retention in the MZ through upregu-
lation of aLb2 and a4b1.
Enhanced Integrin-Linked Survival and Anti-dsDNA
Autoreactivity of MZ B Cells from BAFF-Tg Mice
Because all mice with an enlarged MZ B cell compart-
ment developed autoimmune disease, but mice with
normal or reduced MZ did not, we hypothesized that
an enlarged MZ B cell pool is a prerequisite for develop-
ment of autoimmune disease. Thus, we examined
whether the enlarged CD21hiCD232 MZ B cell pool of
BAFF-Tg mice serves as a niche for autoreactive B cells
by transferring equal amounts of sorted MZ and FO
B cells from BAFF-Tg with confirmed autoimmune dis-
ease into 4-week-old B cell-deficient BAFF-TgmMT
mice. Successful adoptive transfers were verified by
NF-kB Signaling in Autoimmunity
409Figure 5. Altered MZ B Cell Compartments in BAFF-Tg Compound Mutant Mice
(A)Splenocytes from wtanddifferentBAFF-Tgmicewereanalyzedby flowcytometry forexpression ofCD21andCD23. B cells with a MZphenotype
are boxed and their percentages mean6SD, relative to total CD21+ cells, are shown (one representative experiment is shown; n = 3 mice per strain).
(B) Spleen sections from the indicated strains were stained with anti-Moma-1 (red) for sinusoidal macrophages and anti-B220 (green) and anti-IgM
(blue) for B cells. The MZ surrounding the sinus is indicated with an arrow and its diameter is marked with a bar, 103magnification (one represen-
tative section out of three analyzed is shown).
(C) Quantification of integrin gene expression by real-time PCR in purified FO and MZ B cells from different mice (mean6 SD; n = 3).
(D) Flow cytometric analysis of surface integrin expression on B220+CD21+CD23hi-gated FO B cells and B220+CD21hiCD232-gated MZ B cells (n =
3). Mean fluorescence intensity values are shown in Table S1.
(E) Inhibition of integrinsaLb2 anda4b1 relocates MZ B cells to the peripheral circulation. Flow cytometric analysis of spleens and blood from mice 3
hr after i.v. injection of 100 mg, each, of aL and a4 antibodies or isotype-matched control Ig (one representative experiment is shown; values are
means6 SD for three individual mice). Spleens and blood of untreated wt mice are shown for comparison.
Immunity
410Figure 6. Autoreactive B Cells Accumulate in the MZ
(A) Top: dsDNA autoantibody titers of IgG subclasses from BAFF-TgmMT mice transplanted with either MZ B cells or FO B cells. Values represent
mean 6 SD relative OD405 (n = 3) at indicated times after adoptive transfer. Bottom: Relative total serum IgG amounts in these mice.
(B) Top: Immunoblot analysis of extracts of isolated FO and MZ B cells from different strains with phospho-AKT Ser473 and AKT antibodies.
Bottom: Intracellular flow cytometric analysis of B220+CD21hiCD232-gated splenic B cells from wt and BAFF-Tg mice stained with phospho-
AKT Ser473 antibody (results from BAFF-TgIkkaAA/AA mice are very similar to those of wt mice, data not shown; n = 3).
(C) Top: Analysis of MZ and FO B cell adhesion to VCAM-1- and VCAM-1 plus ICAM-1-coated plastic dishes. Where indicated, adhesion was
blocked by inclusion of a4 antibody for VCAM-1 and a4 plus aL antibodies for VCAM-1 plus ICAM-1-coated plates. Bottom: Survival of adherent
or nonadherent MZ B cells from BAFF-Tg mice was determined by trypan blue exclusion. Shown are mean values at different times after plating
(mean 6 SD; n = 3).
(D) Immunoblot analysis with phospho-AKT Ser473 and AKT antibodies of MZ B cells plated on plastic dishes coated with either VCAM-1 plus
ICAM-1 or albumin and, where indicated, incubated with BAFF (#) or LY294002 (*). Cell extracts were prepared at indicated times after plating.
NF-kB Signaling in Autoimmunity
411immunohistology (Figure S7). Serum IgG anti-dsDNA
subclasses of the transplanted mice were monitored bi-
weekly, starting 2 weeks after transplantation (Fig-
ure 6A). Initially, mice receiving MZ B cells from BAFF-
Tg donors produced more IgG autoantibodies than
mice receiving FO B cells, whereas total serum IgG pro-
duction was similar in both recipients. With time, how-
ever, BAFF-TgmMT mice that received FO B cells also
exhibited elevated titers of IgG autoantibodies. Immu-
nohistology of spleens from such mice revealed that
some of the FO B cells had migrated into the MZ
(Figure S7). In contrast, BAFF-TgmMT mice that were
transplanted with MZ or FO B cells from wt donors failed
to produce measurable IgG autoantibodies within 4
weeks posttransplantation (data not shown). These re-
sults suggest that excessive BAFF induces appearance
of autoreactive B cells preferentially within the MZ
compartment.
The importance of the MZ as a niche for pathogenic
autoreactive B cells was further supported by the ab-
sence of marked IgG autoantibody titers in BAFF-
TgmMT mice transplanted with aLb2-deficient BM cells
(Figure S8A). While these mice show substantial TI class
switching, indicating that their antigen presentation is
intact (Figure S8B), they do not form a MZ (not shown).
In the MZ, autoreactive B cells may receive additional
prosurvival signals not available elsewhere. Indeed, im-
munoblot analysis revealed strong AKT (PKB) phos-
phorylation at Ser473 in MZ B cells from BAFF-Tg
mice, which was considerably weaker in FO B cells of
the same mice (Figure 6B, top). Little AKT Ser473 phos-
phorylation was seen in MZ or FO B cells from wt or
BAFF-TgIkkaAA/AA mice. Flow cytometry of splenic MZ
B cells stained with phospho-AKT Ser473 antibody
yielded similar results (Figure 6B, bottom).
BAFF increased integrin expression preferentially on
MZ B cells, so we investigated whether integrin binding
to VCAM-1 or VCAM-1 plus ICAM-1 affected MZ B cell
survival by activating AKT. MZ B cells plated on plastic
dishes coated with either VCAM-1 or VCAM-1 plus
ICAM-1 exhibited greater adhesion than FO B cells
from the same strain (Figure 6C, top). MZ B cells from
BAFF-Tg mice developed higher adhesion activity than
MZ B cells from wt or BAFF-TgIkkaAA/AA mice. Impor-
tantly, adhesion of MZ B cells from any of these strains
resulted in increased survival (Figure 6C, bottom) and
AKT Ser473 phosphorylation (Figure 6D). AKT Ser473
phosphorylation was not increased by the addition of
BAFF to the medium, ruling out a direct contribution of
BAFF to AKT Ser473 phosphorylation during this exper-
iment. The phosphatidylinositol 3-kinase (PI3K) inhibitor
LY290042 prevented AKT Ser473 phosphorylation, indi-
cating that phosphorylation is PI3K dependent. These
findings were also verified by flow cytometry (data not
shown).
Our results suggest that some of the BAFF-induced
survival signals in MZ B cells may be mediated through
integrin ligation resulting in AKT activation. However,
given the discrepancy between the strong AKT Ser473
phosphorylation found in MZ B cells of BAFF-Tg miceand the relatively weak AKT phosphorylation in purified
B cells after integrin ligation, it appears that other mech-
anisms also contribute to AKT activation in BAFF-Tg
mice.
We next examined whether BAFF causes MZ B cells
to lose self-tolerance in a T cell-independent manner.
To test this, we injected apoptotic fetal liver cells into
BAFF-TgRag22/2 and Rag22/2 mice that were trans-
planted 3 days earlier with equal amounts of purified
MZ or FO B cells from healthy 4-week-old wt mice. Suc-
cessful adoptive transfers were verified by immunohis-
tology (data not shown). Within a few days of injection
of apoptotic cells, BAFF excess led to a marked in-
crease in production of dsDNA IgM and IgG antibodies
in mice that received MZ B cells but not in mice trans-
planted with FO B cells (Figure 6E). No significant in-
crease in autoantibody titers could be found in MZ B
cell-transplanted Rag22/2 mice without the Baff trans-
gene. These findings indicate that BAFF excess may
cause MZ B cells to lose self-tolerance independently
of T cells.
Discussion
We demonstrate that the alternative NF-kB pathway,
based on IKKa-catalyzed NF-kB2-p100 processing
(Bonizzi and Karin, 2004), is indispensable for enhanced
survival of peripheral B cells and development of SLE-
like autoimmune disease in BAFF-Tg mice. Autoimmu-
nity (i.e., production of autoantibodies) without progres-
sion to autoimmune disease (i.e., organ lesions) was
observed in BAFF-Tg mice with a defective classical, but
intact alternative, NF-kB pathway. Thus, full-blown au-
toimmune disease in BAFF-Tg mice depends on both
NF-kB pathways. However, neither CD40-mediated B
cell-T cell interactions nor GC formation have a role in
the pathogenesis of the disease in BAFF-Tg mice.
Our results indicate that BAFF activates the classical
NF-kB pathway not only via BCMA and TACI, as previ-
ously suggested (Claudio et al., 2002), but also through
BAFF-R, although activation of the classical pathway
by BAFF-R was weak compared to the TACI-generated
response. A role of BAFF-R in activation of the classical
NF-kB pathway was recently reported (Sasaki et al.,
2006). Both NF-kB-signaling pathways contributed to
BAFF-enhanced B cell survival in vitro. BAFF-induced
survival of BAFF-R-deficient B cells was similar to that
of B cells with a defective alternative NF-kB pathway,
while survival responses of TACI-deficient B cells re-
sembled those of B cells defective in classical NF-kB
signaling. Even though the effect of BAFF on in vitro B
cell survival is mediated through both NF-kB pathways,
each pathway makes a distinct contribution to expres-
sion of antiapoptotic genes. Whereas activation of either
pathway enhanced expression of the antiapoptotic pro-
teins A1/Bfl1 and Bcl-XL, induction of Pim-2 kinase was
exclusively dependent on the alternative pathway. Loss
of Pim-2 caused a similar defect in BAFF-induced in vitro
survival as the one caused by NF-kB2 or BAFF-R defi-
ciency. It should be noted, however, that loss of Pim-2(E) The indicated mice were transplanted with wt MZ or FO B cells and after 3 days injected with apoptotic fetal liver cells. dsDNA autoantibody
titers were monitored at the indicated times after apoptotic cell injections. Values represent mean6 SD relative OD405 (n = 3). Asterisks indicate
significance relative to autoantibody titers from wt mice (p < 0.05).
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2004), suggesting compensation by other survival fac-
tors not available in vitro.
Besides its effect on mature B cells, BAFF enhanced
survival of transitional B cells, leading to increased T1
and T2 B cell pools, and this process depended mainly
on the alternative pathway. Importantly, only BAFF-Tg
and BAFF-Tg compound mutants that possessed an en-
larged transitional B cell pool showed measurable titers
of circulating autoreactive IgM, supporting the hypothe-
sis that the transitional B cell stage may represent a de-
cisive checkpoint for elimination of self-reactivity (Yura-
sov et al., 2005). Because we found IgG and IgA
autoantibodies solely in mice that produced IgM auto-
antibodies, the former types of autoantibodies are likely
to have originated from IgM-producing autoreactive B
cells (Rolink et al., 1996).
An association between factors that enhance TI class
switching and production of pathogenic autoantibodies
was reported (Peng et al., 2002). BAFF strongly pro-
moted TI Ig class switching, and this process mainly de-
pended on an intact classical NF-kB pathway and TACI.
In parallel, induction by BAFF of p50:p65 dimers as well
as p50 homodimers also required intact classical NF-kB
signaling and the presence of TACI. These observations
are consistent with p50 homodimers acting as an iso-
type-specific ‘‘switching factor’’ (Kenter et al., 2004)
and suggest that the promoting effect of BAFF on Ig
class switching may be mediated by these NF-kB iso-
forms. This suggestion is supported by our observation
that BAFF did not promote in vitro class switching in B
cells lacking NF-kB1. While BAFF-TgTACI- (data not
shown) and TACI-deficient mice showed some Ig class
switching and, consequently, developed a mild autoim-
mune disease (von Bulow et al., 2001), BAFF-TgNfkb12/2
mice that had much less class switching and little or no
detectable autoreactive IgG developed no autoimmune
disease. This underscores the importance of Ig class
switching for generation of pathogenic autoantibodies.
Adoptive B cell transfers into BAFF-TgRag22/2, and
injection of Tcrbd2/2 mice with BAFF, indicated that ex-
cessive BAFF can promote class switching after TI anti-
gen immunization independently of T cells. It remains to
be seen, however, whether these mice will develop an
overt SLE-like autoimmune disease similar to BAFF-Tg
mice.
Similar to BAFF-TgNfkb12/2 mice, BAFF-TgIkkaAA/AA
mice failed to produce pathogenic IgG autoantibodies,
even though they showed measurable amounts of au-
toreactive IgM, but, unlike BAFF-TgNfkb12/2 mice, ex-
hibited some Ig class switching upon stimulation with
TI antigens. In search for a possible explanation for
these observations, we found that spleens of BAFF-
TgIkkaAA/AA mice lacked a proper MZ. The MZ is unique
to the spleen and is populated by a special subset of B
cells and other leukocytes, including macrophages
and dendritic cells (Lopes-Carvalho et al., 2005). It was
suggested that MZ B cells, along with peritoneal B1 B
cells, play an important role in ‘‘innate-like’’ TI antigen
responses and may be involved in autoimmune pro-
cesses (Lopes-Carvalho and Kearney, 2004; Martin
et al., 2001). We excluded a major contribution of perito-
neal B1 B cells to BAFF-induced autoimmune disease
because these cells were present in splenectomizedBAFF-Tg mice (data not shown), which developed no
or very mild disease. As we confirmed earlier reports
on BAFF-induced enlargement of the MZ B cell pool
(Schiemann et al., 2001; Thien et al., 2004), MZ B cells
are therefore prime candidates for production of patho-
genic autoreactive antibodies. Indeed, we found a strong
correlation between an enlarged MZ, IgG autoantibody
titers, and development of autoimmune disease. Impor-
tantly, adoptive transfer of B cells from different splenic
compartments of BAFF-Tg mice with known autoim-
mune disease confirmed that CD21hiCD232 MZ B cells
are the major and most immediate source of autoreac-
tive B cells producing pathogenic IgG autoantibodies.
It seems likely that in BAFF-Tg mice, most autoreac-
tive B cells are retained in the MZ by BAFF-induced up-
regulation of aLb2 and a4b1 integrins. Inhibition of integ-
rin interaction with their ligands led to rapid loss of
splenic MZ B cells, confirming the requirement of func-
tional aLb2 and a4b1 for keeping these cells in the MZ.
In the MZ, autoreactive B cells may obtain survival sig-
nals through binding of their integrins to VCAM-1 and
ICAM-1 expressed by MZ stromal cells and macro-
phages in a LTb-R-dependent manner (Dejardin et al.,
2002; Lu and Cyster, 2002). Although mice with defective
LTb ligand-LTb-R axis do not have a MZ, they develop
signs of autoimmunity due to a defect in central toler-
ance induction in the thymus, a mechanism different
from BAFF-mediated autoimmunity (Boehm et al.,
2003). Autoreactive B cells from BAFF-Tg mice without
a properly organized MZ, e.g., BAFF-TgIkkaAA/AA mice,
fail to obtain survival signals through integrin ligation
and may, consequently, die due to reduced competitive-
ness (Lesley et al., 2004). Our proposal that in BAFF-Tg
mice the MZ serves as a critical niche for pathogenic au-
toreactive B cells is further supported by the absence of
marked IgG autoantibody titers in BAFF-TgmMT mice
transplanted with aLb2-deficient BM cells that did not
exhibit a MZ.
Besides the possibility of a defective checkpoint at
the transitional B cell stage as a source for autoreactive
B cells, we obtained more direct evidence that
CD21hiCD232 MZ B cells, but not FO B cells, tend to
lose self-tolerance in a T cell-independent manner under
the influence of excessive BAFF.
We suggest that development of autoimmune disease
in BAFF-Tg mice is a gradual process. Two mechanisms
may explain development of self-reactivity in BAFF-Tg
mice: (1) a defective checkpoint at the transitional B
cell stage leading to survival of constantly appearing au-
toreactive transitional B cells; and (2) a loss of tolerance
of MZ B cells exposed to excessive BAFF, which may
come in contact with self-antigens presented by adja-
cent APCs. BAFF then promotes Ig class switching to
rapidly increase the levels of pathogenic IgG autoanti-
bodies. Further, BAFF-mediated integrin upregulation
retains autoreactive B cells in the MZ and provides
them with critical survival signals. Our findings suggest
that incomplete inhibition of the alternative NF-kB path-
way, as seen in the BAFF-TgIkkaAA/AA mutant, may be
a sufficient therapeutic option for patients suffering
from autoimmune disease associated with BAFF over-
production. As previously discussed (Bonizzi and Karin,
2004), inhibition of the alternative NF-kB pathway is
less likely to cause an immune deficiency, which is
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pathway (Senftleben et al., 2001b; Sha et al., 1995). In
fact, disruption of the alternative NF-kB pathway en-
hances innate immunity (Lawrence et al., 2005).
Experimental Procedures
Mice
BAFF-Tg mice were from L. Gorelik (Biogen Idec, Cambridge, MA)
(Mackay et al., 1999); BAFF-R-deficient mice from K. Rajewsky
(CBR, Harvard University, Boston, MA) (Sasaki et al., 2004); and
TACI-deficient mice from R. Bram (Department of Immunology,
Mayo Clinic, Rochester, MN) (von Bulow et al., 2001). Nfkb22/2
mice were generated by R. Bravo (Bristol Myers Squibb Pharmaceu-
tical Research Institute, Princeton, NJ). Cd402/2, Nfkb12/2, B cell-
deficient mMT, and T cell-deficient Tcrbd2/2mice were from Jackson
Laboratories, and Rag22/2 mice from Taconic Laboratories. Ikka2/2
embryos (Hu et al., 1999) and IkkaAA/AA mice (Cao et al., 2001) were
described. All mouse strains were backcrossed for at least six gen-
erations onto the C57Bl/6 background, and homozygous double
mutant mice were obtained by heterozygote intercrosses. Genotyp-
ing was by PCR. Mice were housed under conventional barrier pro-
tection in accordance with UCSD and NIH guidelines, and mouse
protocols were approved by the UCSD Institutional Animal Care
Committee.
Cell Transplantations
Splenic B cells, BM cells from femurs, or fetal liver cells from 14-day-
old mouse embryos were harvested under sterile conditions and in-
jected (5 3 106 cells, or in case of apoptotic fetal liver cells 1 3 104
cells per mouse) into tail veins of lethally (3000 rad) or, in case of B
cell-deficient recipients, sublethally (600 rad) irradiated mice. BM
cells from aLb2-deficient mice were from D. Corey (Departments
of Pharmacology and Biochemistry, University of Texas Southwest-
ern Medical Center, Dallas, TX). Prior to transplantation of BAFF-
TgmMT mice, spontaneous Ig class switching was excluded by anti-
body isotype analysis with ELISA after TI antigen immunization.
Splenectomy
Mice were splenectomized under anesthesia as described (Reeves
and Reeves, 1991).
Anti-dsDNA ELISA
dsDNA autoantibody titers were analyzed with 96-well MaxiSorp
ELISA plates (Nunc) coated with double-stranded calf thymus DNA
(Enzler et al., 2003; Mackay et al., 1999). AP-labeled anti-mouse
IgM, IgG, IgG subclasses, and IgA (Southern Biotech Associates,
Birmingham, AL) were used to detect different antibody isotypes/
subclasses. Results were normalized to corresponding Ig iso-
types/subclasses (Southern Biotech Associates). Relative ODs
were obtained by comparison to antibody titers of 4-week-old wt
mice.
Flow Cytometry and Cell Sorting
Splenic single-cell suspensions depleted of erythrocytes were incu-
bated with FcgIII/II blocking antibody (PharMingen, San Diego, CA),
following various fluorescent antibodies. FITC-, PE-, APC-, or biotin-
labeled antibodies were either from PharMingen or Santa Cruz Bio-
technology (Santa Cruz, CA) and were to: CD1d, CD3, CD5, CD9,
CD21, CD23, CD24, IgM, IgG subclasses, CD45/B220, AA-4.1, aL,
a4, b1, b2, and a4b7. Binding of biotinylated antibodies was de-
tected by Streptavidin-PE (PharMingen). To exclude dead cells, 25
mg/ml of 7-Amino-actinomycin D (7-AAD) (PharMingen) was added,
where indicated. Data were collected with a FACScalibur flow cy-
tometer and analyzed with CellQuest software (Beckton Dickinson,
San Jose, CA). Cells were also sorted with a Beckton Dickinson
Cell Sorter. Intracellular stainings were done according to the sapo-
nin method (Perez et al., 2004). AKT and phospho-AKT Ser473 anti-
bodies were from Cell Signaling Technology (Beverly, MA).
B Cell Isolations and Analysis
Splenic or peritoneal B cells were isolated with MACS beads cou-
pled to anti-CD43 and anti-CD5 (Miltenyi Biotec) and, where indi-cated, depleted of T cells with anti-CD3 beads (Li et al., 2003). B cells
were cultured as described (Gu and Rajewsky, 2004). Cultures were
stimulated with recombinant human BAFF (0.2 mg/ml) (PeproTech
Inc., Rocky Hill, NJ) and incubated with cycloheximide (25 mg/ml)
(Sigma), where indicated. Mature Ikka2/2 B cells were obtained
from spleens of Ikka2/2 (fetal liver cells)/ mMT radiation chimeras.
Pim22/2B cells were purified fromPim22/2 splenocytes provided by
C. Thompson (Abramson Family Cancer Research Institute, Univer-
sity of Pennsylvania, Philadelphia, PA). Cell proliferation was mea-
sured with the propidium iodide method (Li et al., 2003). Viable cells
were counted by trypan blue exclusion (Enzler et al., 2003). To test B
cell survival in presence of selectins, 12-well culture plates (Corning
Inc., NY) were coated with VCAM-1 or VCAM-1 plus ICAM-1 (R&D
Systems) as described (Lu and Cyster, 2002) and B cells were al-
lowed to adhere in the presence of aL or aL plus a4 antibodies
(both at 0.5 mg/ml, Santa Cruz), where indicated. To some cultures,
10 mM of PI3K inhibitor LY294002 (Cayman Chemical) was added.
Apoptotic Fetal Liver Cells
Cells were plated and UV irradiated (0.42 W/cm2 at 254 nm) for
20 min. Extent of apoptosis was determined and preparations with
>80% apoptotic cells were injected.
Molecular Biology
Real-time PCR was as described (Park et al., 2004). Results were
normalized to the level of cyclophilin mRNA. Individual primer se-
quences are available upon request. Cell fractionation and immuno-
blot analysis was as described (Li et al., 2003). Antibodies to Bcl-XL,
A1/Bfl1, Pim-1, Pim-2, Pim-3, and phospho-Bad Ser112 were from
Santa Cruz Biotechnology, and p100/p52 and IkBa antibodies
were from Upstate (Charlottesville, VA). EMSA and supershift analy-
sis were as described (Senftleben et al., 2001a). Antibodies to p50,
p65, c-Rel, and RelB were from Santa Cruz Biotechnology. p52 an-
tibody was from Upstate. The BAFF antagonist BR3-Fc was kindly
provided by Genentech (San Francisco, CA).
Histochemistry and Immunohistology
Spleens were processed as described (Anzelon et al., 2003). Sec-
tions were stained with B220-FITC, IgM-APC, CD3-FITC (all Phar-
Mingen), Moma-1-biotin antibodies (Bachem Philadelphia Inc.,
King of Prussia, PA), peanut agglutinin-(PNA)-biotin (Vector Labora-
tories, Burlingame, CA), and SAv-Cy3 (Zymed, San Francisco, CA).
Images were captured with a Zeiss Axioplan. Kidneys were fixed
in 10% formalin or frozen. Fixed kidneys were embedded in paraffin
and sections stained with PAS. Renal lesions were scored by an ob-
server blinded to the genotypes (Austin et al., 1984). Specific
changes evaluated were glomerular cellularity, necrosis, crescent
formation, basement membrane thickening, glomerular sclerosis,
and interstitial fibrosis with scores of 0, 1, 2, or 3 for normal, mild,
moderate, or severe pathology. Frozen kidneys were processed as
spleens. Anti-IgG-PE (Jackson Immuno Research) was used to iden-
tify glomerular immune complexes.
Immunizations
To induce GCs, mice were immunized with 100 mg of KLH (Calbio-
chem-Novabiochem Corp., La Jolla, CA) precipitated in alum and
analyzed as described (Anzelon et al., 2003). DNP-KLH in alum
was used to measure TD, and DNP-LPS (Sigma) or DNP-Ficoll (Solid
Phase Sciences) were used to measure TI immune reactions (Haas
et al., 2002). Serum was collected, serially diluted, and added to
96-well Maxisorp ELISA plates, pretreated with 50 ml/well of DNP-
ovalbumin (5 mg/ml) and analyzed as above.
Urinalysis
Protein in urine was measured with Uristix reagent strips (Bayer
Corporation, Elkhart, IN).
Statistical Analysis
To analyze autoantibody titers, Wilcoxon-rank sum tests were used.
A significant level of 0.01 was used as Bonferroni correction for com-
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